230 related articles for article (PubMed ID: 35716884)
1. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
[TBL] [Abstract][Full Text] [Related]
2. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
3. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
[TBL] [Abstract][Full Text] [Related]
4. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
[TBL] [Abstract][Full Text] [Related]
5. Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer.
Zhang F; Li F; Lu GH; Nie W; Zhang L; Lv Y; Bao W; Gao X; Wei W; Pu K; Xie HY
ACS Nano; 2019 May; 13(5):5662-5673. PubMed ID: 31046234
[TBL] [Abstract][Full Text] [Related]
6. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
7. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
[TBL] [Abstract][Full Text] [Related]
8. MOF-based nanozyme grafted with cooperative Pt(IV) prodrug for synergistic anticancer therapy.
Wu PH; Cheng PF; Kaveevivitchai W; Chen TH
Colloids Surf B Biointerfaces; 2023 May; 225():113264. PubMed ID: 36921426
[TBL] [Abstract][Full Text] [Related]
9. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework.
Pan WL; Tan Y; Meng W; Huang NH; Zhao YB; Yu ZQ; Huang Z; Zhang WH; Sun B; Chen JX
Biomaterials; 2022 Apr; 283():121449. PubMed ID: 35247637
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional metal-coordinated Co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis.
Zhao RR; Wu JH; Tong LW; Li JY; Lu YS; Shao JW
J Colloid Interface Sci; 2024 Apr; 660():257-276. PubMed ID: 38244494
[TBL] [Abstract][Full Text] [Related]
11. Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination.
Rao Z; Xia Y; Jia Q; Zhu Y; Wang L; Liu G; Liu X; Yang P; Ning P; Zhang R; Zhang X; Qiao C; Wang Z
J Nanobiotechnology; 2023 Aug; 21(1):265. PubMed ID: 37563614
[TBL] [Abstract][Full Text] [Related]
12. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
[No Abstract] [Full Text] [Related]
13. Hydrazide/Metal/Indocyanine Green Coordinated Nanoplatform for Potentiating Reciprocal Ferroptosis and Immunity against Melanoma.
Hou G; Qian J; Wang Y; Xu W; Guo M; Li Z; Wang J; Suo A
ACS Appl Mater Interfaces; 2023 Aug; 15(31):37143-37156. PubMed ID: 37498789
[TBL] [Abstract][Full Text] [Related]
14. CuS Nanoparticles-Loaded and Cisplatin Prodrug Conjugated Fe(III)-MOFs for MRI-Guided Combination of Chemotherapy and NIR-II Photothermal Therapy.
Qiang S; Hu X; Li R; Wu W; Fang K; Li H; Sun Y; Liang S; Zhao W; Wang M; Lin Y; Shi S; Dong C
ACS Appl Mater Interfaces; 2022 Aug; 14(32):36503-36514. PubMed ID: 35925873
[TBL] [Abstract][Full Text] [Related]
15. Fe(III)-Naphthazarin Metal-Phenolic Networks for Glutathione-Depleting Enhanced Ferroptosis-Apoptosis Combined Cancer Therapy.
Liu Z; Liu S; Liu B; Bian Y; Yuan M; Yang C; Meng Q; Chen C; Ma P; Lin J
Small; 2023 May; 19(19):e2207825. PubMed ID: 36772903
[TBL] [Abstract][Full Text] [Related]
16. Fe-MnO
Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
[TBL] [Abstract][Full Text] [Related]
17. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
[TBL] [Abstract][Full Text] [Related]
18. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
19. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
20. Remodeling the Tumor Microenvironment with Core-Shell Nanosensitizer Featuring Dual-Modal Imaging and Multimodal Therapy for Breast Cancer.
Hou YK; Zhang ZJ; Li RT; Peng J; Chen SY; Yue YR; Zhang WH; Sun B; Chen JX; Zhou Q
ACS Appl Mater Interfaces; 2023 Jan; 15(2):2602-2616. PubMed ID: 36622638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
